Contact Us
Blog
Subscribe to this list via RSS Blog posts tagged in Zofran and pregnancy

Zofran congenital heart defects, Chicago prescription drug defect lawyerParents want their infants and children to be healthy and thrive. It can be a devastating blow when they find out their child may or will have a life-long condition that may be life threatening. Congenital heart defects are heart problems that develop before the child is born and are often referred to as a hole in the heart.  Congenital heart defects can lead to heart failure, high blood pressure, infection, or other problems from the moment they are born or later on in life. In some cases, the congenital heart defect is caused by defective drugs, such as Zofran.

Zofran is manufactured by GlaxoSmithKline and has been approved by the Federal Drug Administration (FDA) for use as an anti-nausea medication for cancer patients going through chemotherapy. It has not been approved, or ever tested or studied, as an anti-nausea drug for pregnant women. This has not stopped GlaxoSmithKline from marketing Zofran for “off-label” use to hospitals and consumers as an anti-nausea medication for pregnant women with severe morning sickness, according to a report from the Department of Justice.

A mother from Oakland, California, filed a lawsuit against GlaxoSmithKline, stating they knew about the negative side effects Zofran caused during the prenatal stages of growth in infants and still marketed the drug to pregnant women. She alleged that the use of Zofran during her pregnancy caused her son’s supraventricular tachycardia, a serious heart defect. Supraventricular tachycardia (SVT) causes the heart to beat too fast or irregularly. It causes an insufficient about of blood supply throughout the body. SVT is treated with medication, surgery, or a combination of both and in the future may cause heart failure.

...

Zofran and pregnancy, Chicago product liability lawyerMany pregnant women experience morning sickness during their pregnancies. Some experience nausea so severe they are unable to function. Most of those women may have been prescribed a drug called Zofran to help with their morning sickness. The problem with Zofran is that it is has not been labeled for use in pregnant women. It is supposed to be used for cancer patients. So why is GlaxoSmithKline allowing their product to be prescribed to women who are pregnant if they have not tested the effects of Zofran on pregnant women? It is medical malpractice to allow their defective drug to continue to be prescribed for uses it is not approved for.

Separate studies have shown a possible link to the use of Zofran in pregnant women in their first trimester and birth defects in their children. Multiple lawsuits filed against GlaxoSmithKline stated Zofran caused birth defects or wrongful deaths after using the drug, that the company marketed the drug to pregnant women without approval from the Food and Drug Administration (FDA), and produced a defective drug. The FDA approved the drug for use in cancer patients during and after treatments and surgeries. It has not been tested for side effects in pregnant women.

This is not the first time Zofran and GlaxoSmithKline have been the subject of a lawsuit for illegal promotion of drugs. The company paid $3 billion as part of the legal settlement in 2012 after federal charges were brought against the company. The company is now being sued by families for specific allegations in relation to the use and misrepresentation of their marketing for Zofran.

...
To Top